These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26895499)

  • 41. Feasibility of transcatheter closure in unselected patients with secundum atrial septal defect, using Amplatzer devices and a modified sizing balloon technique.
    Kammache I; Mancini J; Ovaert C; Habib G; Fraisse A
    Catheter Cardiovasc Interv; 2011 Nov; 78(5):665-74. PubMed ID: 21812090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcatheter closure of secundum atrial septal defects in adults with the Amplatzer septal occluder: intermediate and long-term results.
    Spies C; Timmermanns I; Schräder R
    Clin Res Cardiol; 2007 Jun; 96(6):340-6. PubMed ID: 17323009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices.
    Shrivastava S; Shrivastava S; Allu SVV; Schmidt P
    Cureus; 2023 Jun; 15(6):e40132. PubMed ID: 37425612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events.
    El-Said H; Hegde S; Foerster S; Hellenbrand W; Kreutzer J; Trucco SM; Holzer R; Burch G; Mirani A; Nicolas R; Porras D; Bergersen L; Moore J
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):227-33. PubMed ID: 25257700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ASSURED clinical study: New GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect.
    Sommer RJ; Love BA; Paolillo JA; Gray RG; Goldstein BH; Morgan GJ; Gillespie MJ;
    Catheter Cardiovasc Interv; 2020 Jun; 95(7):1285-1295. PubMed ID: 31943749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Factors influencing the choice of atrial septal occluder for transcatheter closure of secundum atrial septal defects].
    Zhang YS; Lan BD; Li H; He XM; Dai ZX; Wang HC; Zhang J; Li J; DU YJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Nov; 37(11):981-5. PubMed ID: 20137320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immediate and short-term outcomes after percutaneous atrial septal defect closure using the new nit-occlud ASD-R device.
    Peirone A; Contreras A; Ferrero A; da Costa RN; Pedra SF; Pedra CA
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):464-70. PubMed ID: 24677704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Device closure of large atrial septal defects requiring devices > or =20 mm in small children weighing <20 kg.
    Dalvi B; Pinto R; Gupta A
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):679-86. PubMed ID: 18360866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
    Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias.
    Wilson NJ; Smith J; Prommete B; O'Donnell C; Gentles TL; Ruygrok PN
    Heart Lung Circ; 2008 Aug; 17(4):318-24. PubMed ID: 18407789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device.
    Pedra CA; Pedra SF; Costa RN; Ribeiro MS; Nascimento W; Campanhã LO; Santana MV; Jatene IB; Assef JE; Fontes VF
    J Interv Cardiol; 2016 Apr; 29(2):208-15. PubMed ID: 26927945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short- and intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer Septal Occluder.
    Wang JK; Tsai SK; Wu MH; Lin MT; Lue HC
    Am Heart J; 2004 Sep; 148(3):511-7. PubMed ID: 15389241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new "tool" for transcatheter atrial defect closure: the St. Jude SL2™ sheath.
    Lee S; Sutton N; Lopez L; Farooqi K; Mahgerefteh J; Blancas I; Pass RH
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):177-81. PubMed ID: 22431253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraoperative device closure of atrial septal defects with minimal transthoracic invasion: a single-center experience.
    Zhu P; Sun Y; Yang Q; Qiu F
    Tex Heart Inst J; 2013; 40(3):256-60. PubMed ID: 23914014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale.
    Freixa X; Ibrahim R; Chan J; Garceau P; Dore A; Marcotte F; Mercier LA; Mongeon FP; Basmadjian A; Khairy P; Asgar AW
    EuroIntervention; 2013 Sep; 9(5):629-35. PubMed ID: 24058079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ceraflex versus Amplatzer occluder for secundum atrial septal defect closure. Multicenter clinical experience.
    Astarcioglu MA; Kalcik M; Sen T; Aykan AC; Gokdeniz T; Gursoy OM; Karakoyun S; Kulahcioglu S; Gunduz S; Kilit C; Oylumlu M; Amasyali B
    Herz; 2015 Apr; 40 Suppl 2():146-50. PubMed ID: 25662695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk.
    Hill KD; Lodge AJ; Forsha D; Fleming GA; Green AS; Rhodes JF
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):654-9. PubMed ID: 22639441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mid-term outcomes of the Helex septal occluder for percutaneous closure of secundum atrial septal defects.
    Correa R; Zahn E; Khan D
    Congenit Heart Dis; 2013; 8(5):428-33. PubMed ID: 23448373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-Term Outcomes After Percutaneous Closure of Ostium Secundum Atrial Septal Defect in the Young: A Nationwide Cohort Study.
    Jalal Z; Hascoët S; Gronier C; Godart F; Mauri L; Dauphin C; Lefort B; Lachaud M; Piot D; Dinet ML; Levy Y; Fraisse A; Ovaert C; Pillois X; Lusson JR; Petit J; Baruteau AE; Thambo JB
    JACC Cardiovasc Interv; 2018 Apr; 11(8):795-804. PubMed ID: 29673513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects.
    Kenny D; Eicken A; Dähnert I; Boudjemline Y; Sievert H; Schneider MB; Gori T; Hijazi ZM;
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):316-321. PubMed ID: 30719850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.